APP and familial Alzheimer disease: β- and γ- secretase inhibitors decreased Aβ deposits, p-tau-positive cell numbers, and p-tau levels in neurites in fAD ReN cells. 1-AZA and SB41 decreased p-tau in fAD, APP and PSEN1 overexpressed ReN cells.